Global COPD Outlook 2035

A Global Delphi Report on the Future of Prevention, Diagnosis and Care
Download Report
The Global COPD Outlook 2035 report aims to address critical gaps in the understanding, prevention, care and management of Chronic Obstructive Pulmonary Disease (COPD) by leveraging the insights of experts and advocates from around the world.
Chronic obstructive pulmonary disease (COPD) affects an estimated 300 to 400 million people worldwide1 making it the third leading cause of death globally. COPD has a wide range of negative impacts, including individuals’ diminished quality of life and health outcomes, significant social and financial costs, as well as overburdened healthcare systems worldwide.

Public awareness, however, is alarmingly low, with an Ipsos poll revealing that 45% of people cannot correctly identify COPD as a lung disease. This lack of awareness, coupled with insufficient funding and the impact of socioeconomic inequalities, exacerbates the issue.

The systemic burden of COPD and its steady, rising prevalence, with an estimated increase to 600 million people by 2050 with the greatest growth in numbers and higher morbidity in low- and middle-income countries (LMICs) highlight the need for an integrated approach to its prevention and management. This includes raising awareness about COPD, developing a robust understanding of how health systems manage the condition, and identifying the best practices that support its prevention and improve outcomes of COPD patients.

Yes, my country has both a strategy for NCDs and a seperate respiratory health strategy that addresses COPD

No, my country has neither of these

Yes, my country has only a respiratory health strategy that addresses COPD

Yes, my country has only a respiratory health strategy for NCDs

No response

World map in black with various sized translucent colored circles overlaying different countries across North America, South America, Europe, Asia, and Australia.

Existence of national strategies or plans for COPD and NCDs.

Why This Study Matters

The Delphi study highlights key global challenges in prevention, diagnosis, and management of COPD offering actionable solutions to address these gaps.

The overarching goal with this study is to collect the knowledge that would aid in avoiding the unnecessary burden of COPD and achieving better and more equitable health outcomes for COPD patients.

About The Study

The Copenhagen Institute for Futures Studies (CIFS), supported by an independent, expert steering committee, conducted a Delphi study, with the participation of experts from 39 countries, to collect insights on COPD care and expectations on how the future of COPD care will look like. The response period ran from May to August 2024 resulting in 95 responses.

Calls to Action

  • Invest in COPD nurse-led clinics globally, especially in underserved regions, to enhance early intervention and long-term management of COPD.
  • Intensify public awareness campaigns and educational programs to increase COPD recognition, improve prevention efforts, and support patient empowerment.
  • Intensify smoking cessation programs and environmental regulations with good implementation, particularly in regions with highest burden, to reduce COPD incidence.
  • Equip primary care centres with spirometry tools and provide training for healthcare professionals to improve early diagnosis and management of COPD.
  • Develop integrated care pathways to improve coordination between primary, secondary, and tertiary care, facilitating smoother patient transitions and reducing treatment delays.
  • Create national databases for standardised COPD patient data collection, ensuring all healthcare providers can access and share information to improve care coordination and policy development.
  • Develop screening programs for lung function, either as standalone targeted procedure, or integrated into broader chronic disease screening initiatives, to detect COPD early and prevent disease progression.
  • Implement outcome-based reimbursement models that prioritise quality COPD care, encouraging healthcare providers to focus on long-term patient outcomes and reducing overall healthcare costs.
  • Expand digital and telehealth solutions, with an emphasis on user-friendly designs and accessibility, to improve healthcare equity in regions with limited physical healthcare infrastructure.
  • Prioritise the availability of affordable pharmacological treatments for COPD worldwide, addressing both supply chain issues and barriers for patients.

Sanofi and Regeneron provided unrestricted support for the Global COPD Outlook 2035.

The Copenhagen Institute for Futures Studies independently designed the questionnaire and carried out the analysis, along with all insights and recommendations presented in the report.

Contact

Toke Hanghøj
Director, Head of Communication & PR
tot@cifs.dk
+45 26 25 80 44
Søren Høyner
Web Coordinator
sth@cifs.dk
Bugge Holm Hansen
Director, Head of Tech Futures & Innovation
bhh@cifs.dk
+45 30 23 01 70
Sofie Hvitved
Director, Head of Media Futures & Innovation
shv@cifs.dk
+45 20 77 01 44
Adela Bisak
Advisor & Futurist
ab@cifs.dk
+45 33 11 71 76
Aron Szpisjak
Director, Head of Health
as@cifs.dk
+ 45 91 10 61 75
August Leo Liljenberg
Editor
aul@cifs.dk
+45 42 72 21 80
Casper Skovgaard Petersen
Director, Head of Research & Publications
csp@cifs.dk
+45 42 53 32 13
Claus Sneppen
Associated Partner
csn@cifs.dk
+45 26 21 12 21
Gisela Eliasen
Associated Partner
gel@cifs.dk
+45 33 11 71 76
Karoline Sofie Lee
Advisor & Course Coordinator
kfl@cifs.dk
Klaus Æ. Mogensen
Associated Partner
klm@cifs.dk
+45 30 65 11 22
Kristian Mehlsen
Chief Operating Officer (COO), Senior Advisor & Futurist
kme@cifs.dk
+45 31 27 29 60
Magdolna Klára Kovács
Health Advisor & Futurist
mkk@cifs.dk
+45 33 11 71 76
Manya Lind, PhD
Senior Advisor & Futurist
ml@cifs.dk
+45 29 93 31 88
Martin Kruse
Director, Head of Sustainability and Resource
mkr@cifs.dk
+45 30 65 11 04
Monika Volgyi
Advisor & Futurist
mov@cifs.dk
Morten Grønborg
Associated Partner
mgr@cifs.dk
+45 50 45 00 35
Nicklas Larsen
Director, Head of Impact and Development
nl@cifs.dk
+45 31 75 03 85
Patrick Henry Gallen
Senior Advisor & Futurist
phg@cifs.dk
+45 50 20 48 34
Peter Aadal Nielsen
Scientific Advisor
pan@cifs.dk
+45 31 52 55 93
Sara Frostig
Art Director
sf@cifs.dk
Sean Pillot de Chenecey
Associated Partner
spdec@cifs.dk
+44 (0) 772 045 0163
Simon Fuglsang Østergaard
Director, Head of Strategic Foresight & Foresight Training
sio@cifs.dk
+45 31 26 83 26
Tamira Snell
Director, Head of Behaviour
tsn@cifs.dk
+45 26 79 05 85
Thor Svanholm Gustavfson
Senior Advisor & Project Lead
tsv@cifs.dk
+45 28 77 47 97
John Hansen
Associated Partner
+45 33 11 71 76
Lourdes Velasquez Cabrera
Associated Partner
lfvc@cifs.dk
+45 33 11 71 76
Tessa Finlev
Associated Partner
Bogi Eliasen
Fellow
Rodrigo Fernández García
Advisor & Futurist
rfg@cifs.dk
+45 93 94 73 89
Joseph Press
Associated Partner
jp@cifs.dk
Ask Ejlerskov
Advisor & Futurist
ale@cifs.dk
+45 28 19 38 46
Matt Klein
Associated Partner
Joanna Lepore
Associated Partner
Valentina Doorly
Associated Partner
Mikkeline Lykkesfeldt
Advisor
mily@cifs.dk
Torben Rene Uhrenholt
Associated Partner
tru@cifs.dk
Flemming Besenbacher
Fellow
Michael Johansson
Associated Partner
Anton Alfonsin Larsen
Advisor
al@cifs.dk
Mai Britt Romme
Executive Assistant
Mar@cifs.dk
Lucas Duncan
Junior Advisor
ld@cifs.dk
Tallulah Richards
Junior Advisor
tr@cifs.dk
Bente van Baar de Knegt
Junior Advisor
bb@cifs.dk
Adam Gordon
Associated Partner, UNESCO Chair
Carsten Beck
Director & Futurist
cab@cifs.dk
+45 30 65 11 01
Anastasia Allanovna Rytkheu Nørager
Executive PA & Office Manager
ann@cifs.dk
+45 53 53 59 77
Lovisa Volmarsson
Senior Advisor & Futurist
lov@cifs.dk
+45 31 51 10 58
Lasse Jonasson
Chief Foresight Officer
lj@cifs.dk
+45 53 66 00 40
Helle Kallermann
CFO
hek@cifs.dk
+45 30 93 42 43
Nabil Ali Jaloud
Director, Head of Partnerships & Business Development
naj@cifs.dk
+45 31 31 13 22
Jonas Gissel Mikkelsen
Fellow
Daria "Dasha" Krivonos
CEO & Futurist
dka@cifs.dk
+45 29 32 59 31
Thomas Geuken
Associated Director
tg@cifs.dk
+45 28 10 08 38